Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ly 53857

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ly 53857 in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(ly 53857)
Trials
(ly 53857)
Recent Studies (post-2010) (ly 53857)
9,15618755213301

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silbaugh, SA; Stengel, PW1
Baer, PG; Cagen, LM1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ly 53857

ArticleYear
Reversal of A23187-induced airway constriction in the guinea pig.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:3

    Topics: Airway Obstruction; Airway Resistance; Albuterol; Animals; Calcimycin; Dose-Response Relationship, Drug; Ergolines; Guinea Pigs; Leukotrienes; Lung Compliance; Male; Platelet Activating Factor; Serotonin; Thromboxane A2

1989
Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam.
    Hypertension (Dallas, Tex. : 1979), 1987, Volume: 9, Issue:3

    Topics: Alprazolam; Animals; Blood Pressure; Dogs; Ergolines; Female; Kidney; Male; Meclofenamic Acid; Methysergide; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Saralasin; Vascular Resistance; Vasoconstriction

1987